BackUltragenyx Pharmaceutical Overview

Ultragenyx Pharmaceutical Profit Margin

Profitability ratio analysis for RARE.

Quarterly Profit Margin

-136.03%
↓ 25.42% YoY

As of Mar 2026

Annual Profit Margin (TTM)

-91.03%
↑ 2.16% YoY

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin